Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)
NCT00001998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To define the pharmacokinetic characteristics of Nystatin LF IV (intravenous) in human subjects with AIDS-related complex (ARC) after administration of a single IV dose at each of 4 dose levels.
Conditions
- HIV Infections
Interventions
- DRUG
-
Nystatin
Sponsors & Collaborators
-
Argus Pharmaceuticals
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)
NCT00001006 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Zidovudine on the Blood of HIV-Infected Patients
NCT00000965 ·Status: COMPLETED ·Phase: NA
-
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
NCT00000692 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)
NCT00001009 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients
NCT00002013 ·Status: COMPLETED ·Phase: NA
-
Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
NCT00002139 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex
NCT00001011 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)
NCT00002254 ·Status: COMPLETED ·Phase: NA
-
A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC)
NCT00000701 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Itraconazole in Patients With Advanced HIV Infection
NCT00002370 ·Status: COMPLETED ·Phase: NA
-
Depot Disulfiram for AIDS and ARC
NCT00002065 ·Status: COMPLETED ·Phase: NA
-
A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time
NCT00001002 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89
NCT00002141 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
NCT00000999 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body
NCT01045317 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)
NCT00002063 ·Status: COMPLETED ·Phase: NA
-
An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2
NCT00002023 ·Status: COMPLETED ·Phase: NA
-
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
NCT00001995 ·Status: COMPLETED ·Phase: NA
-
A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)
NCT00001008 ·Status: COMPLETED ·Phase: NA
-
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites
NCT00000826 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)
NCT00000978 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis
NCT00659971 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zidovudine in HIV-Infected Patients With Liver Disease
NCT00001001 ·Status: COMPLETED ·Phase: NA
-
Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
NCT00002035 ·Status: COMPLETED ·Phase: NA
-
A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)
NCT00002060 ·Status: COMPLETED ·Phase: NA